Laura S. van Dam

731 total citations
18 papers, 558 citations indexed

About

Laura S. van Dam is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Laura S. van Dam has authored 18 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 11 papers in Pulmonary and Respiratory Medicine and 6 papers in Rheumatology. Recurrent topics in Laura S. van Dam's work include Vasculitis and related conditions (10 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers) and Cell Adhesion Molecules Research (5 papers). Laura S. van Dam is often cited by papers focused on Vasculitis and related conditions (10 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers) and Cell Adhesion Molecules Research (5 papers). Laura S. van Dam collaborates with scholars based in Netherlands, United Kingdom and United States. Laura S. van Dam's co-authors include Ton J. Rabelink, Y K Onno Teng, Cees van Kooten, Jaap Bakker, Sylvia W.A. Kamerling, Tineke Kraaij, Hans Ulrich Scherer, Obbo W Bredewold, Friederike Meyer‐Wentrup and Ingeborg M. Bajema and has published in prestigious journals such as PLoS ONE, Kidney International and Frontiers in Immunology.

In The Last Decade

Laura S. van Dam

18 papers receiving 551 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laura S. van Dam Netherlands	12	302	250	141	138	130	18	558
Ayumi Okuyama Japan	11	91 0.3×	113 0.5×	73 0.5×	206 1.5×	97 0.7×	23	445
Imtiaz M Mumtaz Germany	6	283 0.9×	111 0.4×	35 0.2×	229 1.7×	36 0.3×	6	425
Hossein Hemmatazad Switzerland	11	148 0.5×	95 0.4×	157 1.1×	97 0.7×	325 2.5×	26	689
Lavanya Kamesh United Kingdom	8	200 0.7×	176 0.7×	20 0.1×	128 0.9×	165 1.3×	12	578
Quan Zhen Li United States	5	295 1.0×	63 0.3×	31 0.2×	166 1.2×	93 0.7×	8	469
Atsushi Notoya Japan	11	187 0.6×	88 0.4×	131 0.9×	68 0.5×	53 0.4×	28	484
Ymke M. van der Geld Netherlands	11	250 0.8×	470 1.9×	17 0.1×	138 1.0×	104 0.8×	14	608
Yoshitomo Hamano Japan	11	431 1.4×	54 0.2×	32 0.2×	151 1.1×	168 1.3×	23	569
Sang Taek Kim United States	4	414 1.4×	27 0.1×	178 1.3×	280 2.0×	91 0.7×	7	653
Do‐June Min South Korea	9	152 0.5×	35 0.1×	85 0.6×	145 1.1×	150 1.2×	12	458

Countries citing papers authored by Laura S. van Dam

Since Specialization

Citations

This map shows the geographic impact of Laura S. van Dam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura S. van Dam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura S. van Dam more than expected).

Fields of papers citing papers by Laura S. van Dam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura S. van Dam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura S. van Dam. The network helps show where Laura S. van Dam may publish in the future.

Co-authorship network of co-authors of Laura S. van Dam

This figure shows the co-authorship network connecting the top 25 collaborators of Laura S. van Dam. A scholar is included among the top collaborators of Laura S. van Dam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura S. van Dam. Laura S. van Dam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Dam, Laura S. van, Obbo W Bredewold, Jacqueline T. Jonker, et al.. (2022). ExploriNg DUrable Remission with Rituximab in ANCA-associatEd vasculitis (ENDURRANCE trial): protocol for a randomised controlled trial. BMJ Open. 12(9). e061339–e061339. 8 indexed citations

Bredewold, Obbo W, Laura S. van Dam, Jacqueline T. Jonker, et al.. (2021). Compassionate Use of Avacopan in Difficult-to-Treat Antineutrophil Cytoplasmic Antibody–Associated Vasculitis. Kidney International Reports. 7(3). 624–628. 30 indexed citations

Dam, Laura S. van, Sylvia W.A. Kamerling, Obbo W Bredewold, et al.. (2020). Highly Sensitive Flow Cytometric Detection of Residual B-Cells After Rituximab in Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis Patients. Frontiers in Immunology. 11. 566732–566732. 18 indexed citations

Kraaij, Tineke, Laura S. van Dam, Sylvia W.A. Kamerling, et al.. (2020). Long-term effects of combined B-cell immunomodulation with rituximab and belimumab in severe, refractory systemic lupus erythematosus: 2-year results. Nephrology Dialysis Transplantation. 36(8). 1474–1483. 60 indexed citations

Kraaij, Tineke, Laura S. van Dam, Sylvia W.A. Kamerling, et al.. (2020). P127 Long-term effects of combined B-cell immunomodulation with rituximab and belimumab in severe, refractory SLE: two year results rituximab and belimumab combination for severe SLE. Poster presentations. A90.2–A91. 2 indexed citations

Dam, Laura S. van, Obbo W Bredewold, Jaap Bakker, et al.. (2020). PR3-ANCAs predict relapses in ANCA-associated vasculitis patients after rituximab. Nephrology Dialysis Transplantation. 36(8). 1408–1417. 41 indexed citations

Maggen, Charlotte, Daan Dierickx, Pieternella J. Lugtenburg, et al.. (2019). Obstetric and maternal outcomes in patients diagnosed with Hodgkin lymphoma during pregnancy: a multicentre, retrospective, cohort study. The Lancet Haematology. 6(11). e551–e561. 43 indexed citations

Kraaij, Tineke, Laura S. van Dam, Sylvia W.A. Kamerling, et al.. (2019). OP0042 LONG-TERM EFFECTS OF SYNERGETIC B CELL IMMUNOMODULATION WITH RITUXIMAB AND BELIMUMAB COMBINATION TREATMENT IN SEVERE, REFRACTORY SLE: TWO YEAR RESULTS. Annals of the Rheumatic Diseases. 78. 91–92. 1 indexed citations

Dam, Laura S. van, Tineke Kraaij, Sylvia W.A. Kamerling, et al.. (2019). Intrinsically Distinct Role of Neutrophil Extracellular Trap Formation in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Compared to Systemic Lupus Erythematosus. Arthritis & Rheumatology. 71(12). 2047–2058. 64 indexed citations

10.

Dam, Laura S. van, Sylvia W.A. Kamerling, Tineke Kraaij, et al.. (2019). A reverse translational study on the effect of rituximab, rituximab plus belimumab, or bortezomib on the humoral autoimmune response in SLE. Lara D. Veeken. 59(10). 2734–2745. 19 indexed citations

11.

Dam, Laura S. van, Tineke Kraaij, Sylvia W.A. Kamerling, et al.. (2019). A High-throughput Assay to Assess and Quantify Neutrophil Extracellular Trap Formation. Journal of Visualized Experiments. 7 indexed citations

12.

Dam, Laura S. van, et al.. (2019). A High-throughput Assay to Assess and Quantify Neutrophil Extracellular Trap Formation. Journal of Visualized Experiments. 2 indexed citations

13.

Kraaij, Tineke, Sylvia W.A. Kamerling, Laura S. van Dam, et al.. (2018). Excessive neutrophil extracellular trap formation in ANCA-associated vasculitis is independent of ANCA. Kidney International. 94(1). 139–149. 74 indexed citations

14.

Dam, Laura S. van, Ton J. Rabelink, Cees van Kooten, & Y K Onno Teng. (2018). Clinical Implications of Excessive Neutrophil Extracellular Trap Formation in Renal Autoimmune Diseases. Kidney International Reports. 4(2). 196–211. 32 indexed citations

15.

Dam, Laura S. van, Tineke Kraaij, Sylvia W.A. Kamerling, et al.. (2017). Ex Vivo Induced Neutrophil Extracellular Traps Are Intrinsically Different in Anca-Associated Vasculitis and Systemic Lupus Erythematosus. Arthritis & Rheumatism. 69. 1 indexed citations

16.

Versleijen‐Jonkers, Yvonne M.H., Melissa H.S. Hillebrandt-Roeffen, Mark A.J. Gorris, et al.. (2017). Expression and clinical association of programmed cell death-1, programmed death-ligand-1 and CD8+ lymphocytes in primary sarcomas is subtype dependent. Oncotarget. 8(41). 71371–71384. 73 indexed citations

17.

Hamers, Anouk A.J., Laura S. van Dam, José Duarte, et al.. (2015). Deficiency of Nuclear Receptor Nur77 Aggravates Mouse Experimental Colitis by Increased NFκB Activity in Macrophages. PLoS ONE. 10(8). e0133598–e0133598. 53 indexed citations

18.

Dam, Laura S. van, et al.. (2014). The role of programmed cell death‐1 (PD‐1) and its ligands in pediatric cancer. Pediatric Blood & Cancer. 62(2). 190–197. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact